The European Union is collaborating with the Pharmaceutical Inspection Co-operation Scheme to develop similar guides for evaluating inspectorates’ competency. The European Union’s medicines agencies, ...
EU and US regulators are striving to work together on improving GMP inspection efficiencies and avoiding duplication of efforts. The European network of medicines regulatory agencies, co-ordinated by ...
It is very important for pharmaceutical companies to plan carefully for all Good Manufacturing Practice (GMP) inspections, as a successful outcome is required for continued operations. Careful ...
WUXI, China, Oct. 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP ...
The agency hopes to better use global resources and avoid duplicate inspections of foreign facilities. The need to inspect a growing volume of overseas pharmaceutical manufacturers, but limited FDA ...
Shardul Nautiyal, Mumbai Thursday, February 19, 2026, 08:00 Hrs [IST] ...
WUXI, China, April 6, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has successfully ...
The Rosselkhoznadzor informs that from August 1, 2023, applications for obtaining a state service for issuing an opinion on the compliance of a manufacturer of veterinary medicines with the ...
Indian medical device manufacturers are enhancing their Good Manufacturing Practice (GMP) compliance, reinforcing India's role as a trusted global supplier in the healthcare and MedTech sectors. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results